1. Immune responses of TLR5⁺ lamina propria dendritic cells in enterobacterial infection

   • Satoshi Uematsu
   • Shizuo Akira

   Review 24 June 2009 Pages: 803 - 811

   

2. Asymmetrical circumferential distribution of esophagogastric junctional lesions: anatomical and physiological considerations

   • Yoshikazu Kinoshita
   • Kenji Furuta
   • Yuji Amano

   Review 13 June 2009 Pages: 812 - 818

   

3. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication

   • Katsunori Iijima
   • Tomoyuki Koike
   • Tooru Shimosegawa

   Original Article—Alimentary Tract 14 May 2009 Pages: 819 - 825

   

4. The use of indigocarmine spray increases the colonoscopic detection rate of adenomas

   • Kazutomo Togashi
   • David G. Hewett
   • Mark N. Appleyard

   Original Article—Alimentary Tract 16 May 2009 Pages: 826 - 833

   

5. Restoration of gut motility in Kit-deficient mice by bone marrow transplantation

   • Shuji Ishii
   • Shingo Tsuji
   • Norio Hayashi

   Original Article—Alimentary Tract 21 May 2009 Pages: 834 - 841

   

6. Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction?

   • Chika Kusano
   • Tonya Kaltenbach
   • Takuji Gotoda

   Original Article—Alimentary Tract 09 June 2009 Pages: 842 - 846

   

7. The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation

   • Motoki Takashima
   • Christopher J. Parsons
   • Richard A. Rippe

   Original Article—Liver, Pancreas, and Biliary Tract 13 May 2009 Pages: 847 - 855

   

8. Interferon-α-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway

   • Azusa Matsumoto
   • Tatsuki Ichikawa
   • Katsumi Eguchi

   Original Article—Liver, Pancreas, and Biliary Tract 13 May 2009 Pages: 856 - 863

   

9. Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance

   • Nao Kurashige
   • Kazuyoshi Ohkawa
   • Norio Hayashi

   Original Article—Liver, Pancreas, and Biliary Tract 28 May 2009 Pages: 864 - 870

   

10. Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B

    • Holger G. Hass
    • Thomas Bock
    • Stephan Kaiser

    Original Article—Liver, Pancreas, and Biliary Tract 21 May 2009 Pages: 871 - 877